N@N

Market Maker Surveillance Report. DCTH, LPHI, CWTR, XNPT, OHRP, CUI, Winning Stocks With Lowest Price Friction For Friday, Oct

October 5, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4114 companies with "abnormal" market making, 2686 companies with positive Friction Factors and 2640 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Delcath Systems Inc (NASDAQ:DCTH), Life Partners Holdings Inc (NASDAQ:LPHI), Coldwater Creek Inc (NASDAQ:CWTR), Xenoport Inc (NASDAQ:XNPT), OHR Pharmaceutical Inc (OTCBB:OHRP), Currie Rose Resources Inc (NASDAQ:CUI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  DCTH    $0.250    13.74%    2,509,907    61.02%    1,603,421    38.98%    906,486      36,259  
  LPHI    $0.360    16.14%    826,339      56.40%    638,703      43.60%    187,636      5,212   
  CWTR    $0.430    10.94%    295,885      57.86%    215,483      42.14%    80,402       1,870   
  XNPT    $1.710    15.34%    624,456      49.40%    584,844      46.27%    39,612       232     
  OHRP    $0.170    13.28%    78,130       61.65%    47,600       37.56%    30,530       1,796   
  CUI     $0.700    12.50%    109,175      55.88%    81,891       41.91%    27,284       390     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows DCTH with a dollar gain Friday of $0.25000 and a Friction Factor of 36,259 shares. That means that it only took 36,259 more shares of buying than selling to move DCTH higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Delcath Systems Inc (NASDAQ:DCTH) - Delcath Systems, Inc., a development stage company, develops and manufactures devices to administer high dose chemotherapy and other therapeutic agents directly to diseased organs or regions of the body. It focuses on the development of the Delcath PHP System, a Phase III clinical trial product, which isolates the liver from the patients general circulatory system and delivers high dose of melphalan hydrochloride or other therapeutic agents directly to the liver. The Delcath PHP System kit includes an arterial infusion catheter, a multi-passageway/double balloon catheter, a blood tubing filtration circuit, two hemoperfusion filters, a return catheter/a thin-walled blood sheath, and a series of introducers and related accessories to properly place the catheters. The company also conducts Phase II clinical trials to test the Delcath PHP System with melphalan against liver cancer, neuroendocrine tumors, hepatocellular carcinoma, ocular or cutaneous melanoma, and metastatic adenocarcinoma that have spread to the liver, and melanomas metastatic to the liver that have received prior regional treatment. It has a cooperative research and development agreement with the National Cancer Institute to develop and evaluate the Delcath PHP System device. Delcath Systems, Inc. was founded in 1988 and is based in New York, New York..

Life Partners Holdings Inc (NASDAQ:LPHI) - Life Partners Holdings, Inc., through its subsidiary, Life Partners, Inc., operates in the secondary market for life insurance in the United States. It facilitates life settlement transactions by identifying, examining, and purchasing the policies as agent for the purchasers. The companys financial transactions involve the purchase of life insurance policies at a discount to their face value for investment purposes. It serves institutional purchasers, which include investment funds designed to acquire and hold life settlements; and retail purchasers, such as high net worth individuals. The company was founded in 1971 and is based in Waco, Texas..

Coldwater Creek Inc (NASDAQ:CWTR) - Coldwater Creek Inc., together with its subsidiaries, operates as a multi-channel specialty retailer of women's apparel, accessories, jewelry, and gift items primarily in the United States. It operates premium retail stores and merchandise clearance outlet stores; and day spas, which offer various spa treatments, including massages, facials, body treatments, manicures, and pedicures, as well as an assortment of relevant apparel and lines of personal care products for women. The company also offers products through its e-commerce Web site, coldwatercreek.com, as well as through catalogs. As of January 30, 2010, it operated 356 premium retail stores. Coldwater Creek Inc. was founded in 1984 and is headquartered in Sandpoint, Idaho..

Xenoport Inc (NASDAQ:XNPT) - XenoPort, Inc., a biopharmaceutical company, focuses on developing internally discovered product candidates that utilize the bodys natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs. The company licenses its lead product candidate XP13512, a transported prodrug of gabapentin, to Astellas Pharma Inc. in Japan and five Asian countries, as well as to Glaxo Group Limited (GSK) in the United States and internationally. Astellas and GSK filed new drug applications for the approval of XP13512 as a treatment for restless legs syndrome in Japan and the United States. The company also develops Arbaclofen Placarbil, which is under Phase IIb clinical trials for the treatment of gastroesophageal reflux disease. In addition, it develops Arbaclofen Placarbil that has completed Phase II clinical trials for the treatment of spasticity. Further, the company develops XP21279, a transported prodrug of L-Dopa, which has completed Phase I clinical trials for the treatment of Parkinsons disease; and XP21510, a transported prodrug of tranexamic acid, that is in preclinical stages for the treatment of menorrhagia or heavy menstrual bleeding. XenoPort, Inc. has strategic alliances with Astellas Pharma, Inc. and Glaxo Group Limited. The company was founded in 1999 and is based in Santa Clara, California..

OHR Pharmaceutical Inc (OTCBB:OHRP) - Ohr Pharmaceutical, Inc., a biotechnology company, engages in the development of drugs for underserved therapeutic needs. The company is developing OHR/AVR118 for the treatment of cachexia, a condition of physical wasting with loss of weight, fat, and lean muscle mass seen in patients with advanced cancer, AIDS, or other chronic and progressive diseases; and EVIZON for the treatment of wet-AMD, a cause of severe vision loss in people over age 50. Ohr Pharmaceutical is based in Salt Lake City, Utah..

Currie Rose Resources Inc (NASDAQ:CUI) - .

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net